Publications
2 shownSotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
In this phase 2 trial, sotorasib therapy led to a durable clinical benefit without new safety signals in patients with previously treated <i>KRAS</i> p.G12C-mutated NSCLC. (Fund...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 3,922
- Institution
- Deutschen Konsortium für Translationale Krebsforschung
External Links
Identifiers
- ORCID
- 0000-0002-2166-3394
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.